A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...

Willy Goldschmidt is among a group of patients from University Hospitals Coventry and Warwickshire NHS Trust who have taken ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

Real Housewives of Beverly Hills' Teddi Mellencamp said "everything’s good as it can be" amid her cancer battle after her ...

Real Housewives of Beverly Hills' Teddi Mellencamp said "everything’s good as it can be" amid her cancer battle after her ...

A viral claim says cancer can be destroyed without surgery using MRI and extreme cold. Breakthrough or hype? Here's what ...

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

Radiotherapy professionals from 10 Asian countries have completed an IAEA training course on ultra-hypofractionated radiotherapy — a way of treating cancer with ionizing radiation that reduces ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.